Abstract:Abstract BACKGROUND AND AIMS Higher mean corpuscular volume (MCV), a measure of the average size of the circulating erythrocyte used for differential diagnosis of anemia or for monitoring macrocytosis, is associated with higher mortality in various clinical settings including in patients (pts) with kidney failure; however, results are not consistent and a study from Japan (Honda et al. Low rather than high mean corpuscular volume is associated with mortality in Japanese patients under hemodialysis. Sci Rep. 2020; 10(1): 15 663) found that low MCV associated with mortality in 8571 hemodialysis pts (mean age 62.5 ± 12.7 years, 37.2% female, median MCV 96.1 fL) pts. We investigated the relationship between MCV with all-cause and cardiovascular mortality in two cohorts of kidney failure pts from China and Sweden. METHOD In 731 incident Chinese peritoneal dialysis pts (median age 50 years, 57% males) and 404 Swedish kidney failure pts (median age 56 years, 62% males), baseline MCV and other biochemical and metabolic biomarkers were analysed in relation to mortality during follow-up period of up to 5 years. All-cause and cardiovascular disease (CVD) mortality risk were analysed with competing-risk regression models with transplantation as competing risk adjusting for age, sex, smoking, diabetes, serum albumin, hemoglobulin and calendar year. RESULTS Chinese pts were significantly younger (P < 0.01) and had lower body mass index (P < 0.01) and Framingham risk score (P < 0.01) than Swedish pts while gender distribution was similar. In univariate analysis, MCV was associated with body mass index (P < 0.01) and mean arterial blood pressure (P < 0.01) in both cohorts. ‘Chinese pts’: During median 3.6 years of follow-up, all-cause mortality rate was 16%, and 52 (46%) of 111 deaths were caused by CVD. Low MCV (<94 fL) was associated with significantly higher all-cause [Fig. 1A; sub-hazard ratio, sHR (95% CI) 2.15 (1.14–4.06)] but not CVD mortality (Fig. 2A) when adjusting for all confounders. ‘Swedish pts’: During median 2.1 years of follow-up, all-cause mortality rate was 30%, and 53 (44%) of the 120 deaths were caused by CVD. In contrast to the Chinese cohort, pts low MCV (<94 fL) was associated with lower both all-cause [Fig. 1B; sHR 0.62 (0.39–0.97)] and CVD mortality [Fig. 2B; sHR 0.49 (0.26–0.94)] when adjusting for all confounders. CONCLUSION In Chinese kidney failure pts low MCV was associated with higher all-cause mortality risk while in Swedish kidney failure pts low MCV was associated with pts lower all-cause and CVD mortality risk, independently of all confounders. Further studies are needed to explore if this difference may reflect regional differences in factors affecting MCV.

Hemoglobin variability and all-cause mortality in hemodialysis patients: A systematic review and meta-analysis.

SUN-084 HEMOGLOBIN VIARIABILITY AND MORTALITY OF PERITONEAL DIALYSIS PATIENTS

Relationship between hemoglobin variability and prognosis in dialysis patients

Long‐term Predialysis Blood Pressure Variability and Outcomes in Hemodialysis Patients

Long-Term Predialysis Systolic Blood Pressure Variability and Intradialytic Cardiac Hemodynamics in Hemodialysis Patients

The relationship between the level and variability of serum uric acid and mortality in hemodialysis patients

Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis

Revisiting management of renal anemia:correlation between hemoglobin variability and prognosis

MO673: Association of Mean Corpuscular Volume with Mortality in Kidney Failure Patients: Opposite Findings in Chinese and Swedish Kidney Failure Patients

Interdialytic home systolic blood pressure variability increases all‐cause mortality in hemodialysis patients

Clinical Research on Hemoglobin Variability in Maintenance Hemodialysis Patients

Analysis of early mortality and related risk factors in maintenance hemodialysis patients

A meta‐analysis of the relationship between glycaemic variability and the mortality of patients with heart failure

Increased Mortality Associated with Higher Pre-Dialysis Serum Sodium Variability: Results of the International MONitoring Dialysis Outcome Initiative

Associations between serum potassium variability and mortality in patients undergoing maintenance hemodialysis: a retrospective study

P1493CORRELATION BETWEEN END-DIALYSIS OVER-WEIGHT IN INITIAL STAGE OF HEMODIALYSIS AND PROGNOSIS IN INCIDENT HEMODIALYSIS PATIENTS

Vitamin D Status and Mortality Risk among Patients on Dialysis: a Systematic Review and Meta-Analysis of Observational Studies.

Impact of peritoneal dialysis and hemodialysis on mortality in patients with end-stage renal disease: A systematic review and meta-analysis

Heart rate variability predicts mortality in peritoneal dialysis patients

Intradialytic BP Variability is Associated with Cardiovascular Mortality and Hospitalization in HD Patients

Risk factors for mortality in elderly haemodialysis patients: a systematic review and meta-analysis